To determine if there is also a negative association between AQP1 and THSD7A expression in the tumors of patients with GBM, we assessed their expression in sections of 33 different GBM clinical specimens by immunohistochemistry (Figure 6C,D). The gene discussed is THSD7A; the disease is glioblastoma.